APN
APN
APN - Aspen Pharmacare Holdings Limited - Trading statement
Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN & ISIN: ZAE000066692
("Aspen")
Trading statement
Aspen shareholders are hereby advised that earnings per share, for the 6
months ended 31 December 2011, are expected to exceed those reported in the
comparative period, ended 31 December 2010, by 24% to 30%. The growth in
earnings per share has benefited from the disposal of the discontinued
businesses and products.
Headline earnings per share and diluted normalised headline earnings per
share from continuing operations, adjusted for transaction and restructure
costs are both expected to exceed those of the comparative period by 17% to
23%.
The financial results on which this trading announcement is based have not
been reviewed or reported on by Aspen`s external auditors.
Aspen`s interim results are scheduled to be published on SENS on 7 March
2012.
Woodmead
21 February 2012
Sponsor: Investec Bank Limited
Date: 21/02/2012 09:05:11 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
